CD8+ T cells in the HNSCC TME interactome, particularly with macrophages, are based on predicted CD274–PDCD1, HAVCR2–LGALS9, and TIGIT–NECTIN2 interactions that may dictate tumor rejection. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.